Choosing thresholds for statistical signal detection with the proportional reporting ratio

Drug Safety

Volumn 36, Issue 8, 2013, Pages 687-692

  Slattery, Jim ^a   Alvarez, Yolanda ^a   Hidalgo, Ana ^a  

^a EUROPEAN MEDICINES AGENCY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ARTICLE; DATA BASE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FALSE POSITIVE RESULT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPORTIONAL REPORTING RATIO; SENSITIVITY AND SPECIFICITY; SIGNAL DETECTION; STATISTICAL ANALYSIS;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ALGORITHMS; DECISION MAKING; HUMANS; MODELS, STATISTICAL;

EID: 84881137475     PISSN: 01145916     EISSN: 11791942     Source Type: Journal    
DOI: 10.1007/s40264-013-0075-1     Document Type: Article

References (12)

1. Finney DJ. Statistical logic in the monitoring of adverse reactions to therapeutic drugs. Methods Inf Med. 1971;10:237-42.
2. Alvarez Y, Hidalgo A, Maignen F, Slattery J. Validation of statistical signal detection procedures in EudraVigilance post-authorisation data: a retrospective evaluation of the potential for earlier signalling. Drug Saf. 2010;33(6):475-87.
3. Council Regulation (EEC) No 2309/93 of 22 July 1993 laying down Community procedures for the authorization and supervision of medicinal products for human and veterinary use and establishing a European Agency for the Evaluation of Medicinal Products. http://ec.europa.eu/health/files/eudralex/vol-1/reg-1993- 2309/reg-1993-2309-en.pdf. Accessed 16 May 2013.
4. MedDRA and MSSO. http://www.meddramsso.com. Accessed 18 Dec 2012.
5. European Medicines Agency. EudraVigilance. http://eudravigilance.emea. europa.eu/highres.htm. Accessed 18 Dec 2012.
6. Evans SJW, Waller P, Davis S. Use of proportional reporting ratios (PRR) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf. 2001;10:483-6.
7. EudraVigilance Expert Working Group. Guideline on the use of statistical signal detection methods in the EudraVigilance data analysis system (EMEA/106464/2006 rev.1). http://www.emea.europa.eu/pdfs/human/phvwp/ 10646406enfin.pdf. Accessed 18 Dec 2012.
8. Pharmacoepidemiological Research on Outcomes of Therapeutics by a European Consortium. http://www.imi-protect.eu/. Accessed 18 Dec 2012.
9. Matsushita Y, Kuroda Y, Niwa S, Sonehara S, Hamada C, Yoshimura I. Criteria revision and performance comparison of three methods of signal detection applied to the spontaneous reporting database of a pharmaceutical manufacturer. Drug Saf. 2007;30(8):715-26.
10. Almenoff J, LaCroix K, Yuen N, et al. Comparative performance of two quantitative safety signalling methods. Drug Saf. 2006;29(10):875-87.
11. Ahmed I, Thiessard F, Miremont-Salame G, et al. Early detection of pharmacovigilance signals with automated methods based on false discovery rates. Drug Saf. 2012;35(6):495-506.
12. Berlin C, Blanch C, Lewis D, et al. Are all quantitative postmarketing signal detection methods equal? Performance characteristics of logistic regression and multi-item Gamma Poisson Shrinker. Pharmacoepidemiol Drug Saf. 2012;21:622-30.